9,027 research outputs found
DACH1: its role as a classifier of long term good prognosis in luminal breast cancer
Background: Oestrogen receptor (ER) positive (luminal) tumours account for the largest proportion of females with breast cancer. Theirs is a heterogeneous disease presenting clinical challenges in managing their treatment. Three main biological luminal groups have been identified but clinically these can be distilled into two prognostic groups in which Luminal A are accorded good prognosis and Luminal B correlate with poor prognosis. Further biomarkers are needed to attain classification consensus. Machine learning approaches like Artificial Neural Networks (ANNs) have been used for classification and identification of biomarkers in breast cancer using high throughput data. In this study, we have used an artificial neural network (ANN) approach to identify DACH1 as a candidate luminal marker and its role in predicting clinical outcome in breast cancer is assessed. Materials and methods: A reiterative ANN approach incorporating a network inferencing algorithm was used to identify ER- associated biomarkers in a publically available cDNA microarray dataset. DACH1 was identified in having a strong influence on ER associated markers and a positive association with ER. Its clinical relevance in predicting breast cancer specific survival was investigated by statistically assessing protein expression levels after immunohistochemistry in a series of unselected breast cancers, formatted as a tissue microarray. Results: Strong nuclear DACH1 staining is more prevalent in tubular and lobular breast cancer. Its expression correlated with ER-alpha positive tumours expressing PgR, epithelial cytokeratins (CK)18/19 and 'luminal-like' markers of good prognosis including FOXA1 and RERG (p , 0.05). DACH1 is increased in patients showing longer cancer specific survival and disease free interval and reduced metastasis formation (p , 0.001). Nuclear DACH1 showed a negative association with markers of aggressive growth and poor prognosis. Conclusion: Nuclear DACH1 expression appears to be a Luminal A biomarker predictive of good prognosis, but is not independent of clinical stage, tumour size, NPI status or systemic therapy
Enhanced breast Cancer Relapse Prediction Based on Ensemble Learning Approaches
Predicting progression and deciding on the best follow-up techniques for breast cancer patients is difficult because the illness is diverse and characterized by varying relapse risks. Due to its prevalence, breast cancer has become the top cause of mortality among women worldwide, making diagnosis and prognosis particularly challenging areas of medical study. In addition, the fear of a cancer relapse is a major factor influencing cancer patients' quality of life. The study aims to help doctors determine the likelihood of a breast cancer relapse by applying ensemble learning techniques. In this research, artificial neural networks (ANN) and deep neural networks (DNN) ensembled with Weighted averaging, minority, and majority voting approaches have been investigated for performance enhancements on the breast cancer recurrence dataset sourced from the UCI-ML repository. The empirical analysis shows that this ensemble learning-enabled proposed novel approach shows improved accuracy, precision, sensitivity, specificity, and F1-score of 96.21%, 96.59%, 98.84%, 84.62%, and 97.41%, respectively. The findings of this study can aid doctors in making more informed treatment decisions, thereby improving patient outcomes
Joint and individual analysis of breast cancer histologic images and genomic covariates
A key challenge in modern data analysis is understanding connections between
complex and differing modalities of data. For example, two of the main
approaches to the study of breast cancer are histopathology (analyzing visual
characteristics of tumors) and genetics. While histopathology is the gold
standard for diagnostics and there have been many recent breakthroughs in
genetics, there is little overlap between these two fields. We aim to bridge
this gap by developing methods based on Angle-based Joint and Individual
Variation Explained (AJIVE) to directly explore similarities and differences
between these two modalities. Our approach exploits Convolutional Neural
Networks (CNNs) as a powerful, automatic method for image feature extraction to
address some of the challenges presented by statistical analysis of
histopathology image data. CNNs raise issues of interpretability that we
address by developing novel methods to explore visual modes of variation
captured by statistical algorithms (e.g. PCA or AJIVE) applied to CNN features.
Our results provide many interpretable connections and contrasts between
histopathology and genetics
Passively mode-locked laser using an entirely centred erbium-doped fiber
This paper describes the setup and experimental results for an entirely centred erbium-doped fiber laser with passively mode-locked output. The gain medium of the ring laser cavity configuration comprises a 3 m length of two-core optical fiber, wherein an undoped outer core region of 9.38 μm diameter surrounds a 4.00 μm diameter central core region doped with erbium ions at 400 ppm concentration. The generated stable soliton mode-locking output has a central wavelength of 1533 nm and pulses that yield an average output power of 0.33 mW with a pulse energy of 31.8 pJ. The pulse duration is 0.7 ps and the measured output repetition rate of 10.37 MHz corresponds to a 96.4 ns pulse spacing in the pulse train
PaperRobot: Incremental Draft Generation of Scientific Ideas
We present a PaperRobot who performs as an automatic research assistant by
(1) conducting deep understanding of a large collection of human-written papers
in a target domain and constructing comprehensive background knowledge graphs
(KGs); (2) creating new ideas by predicting links from the background KGs, by
combining graph attention and contextual text attention; (3) incrementally
writing some key elements of a new paper based on memory-attention networks:
from the input title along with predicted related entities to generate a paper
abstract, from the abstract to generate conclusion and future work, and finally
from future work to generate a title for a follow-on paper. Turing Tests, where
a biomedical domain expert is asked to compare a system output and a
human-authored string, show PaperRobot generated abstracts, conclusion and
future work sections, and new titles are chosen over human-written ones up to
30%, 24% and 12% of the time, respectively.Comment: 12 pages. Accepted by ACL 2019 Code and resource is available at
https://github.com/EagleW/PaperRobo
Elephant Search with Deep Learning for Microarray Data Analysis
Even though there is a plethora of research in Microarray gene expression
data analysis, still, it poses challenges for researchers to effectively and
efficiently analyze the large yet complex expression of genes. The feature
(gene) selection method is of paramount importance for understanding the
differences in biological and non-biological variation between samples. In
order to address this problem, a novel elephant search (ES) based optimization
is proposed to select best gene expressions from the large volume of microarray
data. Further, a promising machine learning method is envisioned to leverage
such high dimensional and complex microarray dataset for extracting hidden
patterns inside to make a meaningful prediction and most accurate
classification. In particular, stochastic gradient descent based Deep learning
(DL) with softmax activation function is then used on the reduced features
(genes) for better classification of different samples according to their gene
expression levels. The experiments are carried out on nine most popular Cancer
microarray gene selection datasets, obtained from UCI machine learning
repository. The empirical results obtained by the proposed elephant search
based deep learning (ESDL) approach are compared with most recent published
article for its suitability in future Bioinformatics research.Comment: 12 pages, 5 Tabl
Machine Learning and Integrative Analysis of Biomedical Big Data.
Recent developments in high-throughput technologies have accelerated the accumulation of massive amounts of omics data from multiple sources: genome, epigenome, transcriptome, proteome, metabolome, etc. Traditionally, data from each source (e.g., genome) is analyzed in isolation using statistical and machine learning (ML) methods. Integrative analysis of multi-omics and clinical data is key to new biomedical discoveries and advancements in precision medicine. However, data integration poses new computational challenges as well as exacerbates the ones associated with single-omics studies. Specialized computational approaches are required to effectively and efficiently perform integrative analysis of biomedical data acquired from diverse modalities. In this review, we discuss state-of-the-art ML-based approaches for tackling five specific computational challenges associated with integrative analysis: curse of dimensionality, data heterogeneity, missing data, class imbalance and scalability issues
- …